www.public4you.fora.pl

saleyrxgah

The FDA advisory committee has nine members and includes physicians,[link widoczny dla zalogowanych], scientists and public health experts; the tobacco industry is represented by three non-voting members. The committee has until March 2011 to report its menthol findings to the U.S. Secretary of Health and Human Services. More information The National Survey on Drug Use and Health has more on menthol cigarettes.
SOURCES: Bill True, senior vice president, research and development, Lorillard Tobacco Co., Greensboro, N.C.; Mitch Zeller, J.D., vice president,[link widoczny dla zalogowanych], policy and strategic communications, Pinney Associates, Washington, D.C.; Ellen Vargyas,[link widoczny dla zalogowanych], J.D.,[link widoczny dla zalogowanych], general counsel, American Legacy Foundation,[link widoczny dla zalogowanych], Washington, D.C.; HR 1256: Family Smoking Prevention and Tobacco Control Act; National Cancer Institute, Tobacco Control Research Brand, Research Topics: Menthols and Tobacco;
Harvard School of Public Health.; Palm Beach Post, June 28, 2010; International Journal of Clinical Practice, 2009. WINSTON-SALEM, N.C. — Customers may already have noticed the change—although it has been subtle thus far. But they will starting March 1. That’s the official launch date of the latest line extension from R.J. Reynolds Tobacco Co.’s Camel brand: menthol cigarettes containing a menthol burst capsule that enhances menthol flavor when squeezed. The new cigarette supplanted Camel Menthol cigarettes in August 2009 and evolved from the “wonderful success” of Camel Crush (launched September 2008), according to Brian Stebbins, senior marketing director for Camel cigarettes.
Crush also contains the menthol capsule,[link widoczny dla zalogowanych], but squeezing it turns that cigarette from nonmenthol to menthol. “Whenever we launch something new, we try to find out who’s interacting with it, who likes it, who doesn’t like it and who has an idea of how to make it even better,” Stebbins told CSP Daily News. ob Bannon,[link widoczny dla zalogowanych], Lorillard’s director of investor relations,[link widoczny dla zalogowanych], says that the expansion of Newport is the company’s way of seizing growth in the nonmenthol market, not a defensive maneuver against menthol regulation. “We do have other nonmenthol brands that the company has sold for many years,” Bannon said.
But he said he understands “it is difficult to entirely disassociate the concept of a nonmenthol product in the context of what’s going on with the FDA.” One analyst said a company that makes even a small change in its top brand is taking a major step. “Since it is a core product and a core feature of a core product, even subtle changes in the product could have significant impact,” said Richard Hastings, a macro and consumer strategist for Global Hunter Securities of Newport Beach, Calif.